Caribou Biosciences Inc.

0.74
-0.05 (-5.73%)
At close: Apr 03, 2025, 3:59 PM

Caribou Biosciences Statistics

Share Statistics

Caribou Biosciences has 93M shares outstanding. The number of shares has increased by 2.97% in one year.

Shares Outstanding 93M
Shares Change (YoY) 2.97%
Shares Change (QoQ) 2.71%
Owned by Institutions (%) 64.42%
Shares Floating 80.81M
Failed to Deliver (FTD) Shares 90
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 10.8M, so 11.93% of the outstanding shares have been sold short.

Short Interest 10.8M
Short % of Shares Out 11.93%
Short % of Float 13.64%
Short Ratio (days to cover) 6.76

Valuation Ratios

The PE ratio is -0.96 and the forward PE ratio is -0.67. Caribou Biosciences's PEG ratio is -0.05.

PE Ratio -0.96
Forward PE -0.67
PS Ratio 14.37
Forward PS 0
PB Ratio 0.57
P/FCF Ratio -1
PEG Ratio -0.05
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Caribou Biosciences.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.16, with a Debt / Equity ratio of 0.1.

Current Ratio 7.16
Quick Ratio 7.16
Debt / Equity 0.1
Debt / EBITDA -0.16
Debt / FCF -0.19
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $67.99K
Profits Per Employee $-1.01M
Employee Count 147
Asset Turnover 0.03
Inventory Turnover n/a

Taxes

Income Tax -9K
Effective Tax Rate 0.01%

Stock Price Statistics

The stock price has increased by -82.6% in the last 52 weeks. The beta is 2.36, so Caribou Biosciences's price volatility has been higher than the market average.

Beta 2.36
52-Week Price Change -82.6%
50-Day Moving Average 1.18
200-Day Moving Average 1.78
Relative Strength Index (RSI) 30.29
Average Volume (20 Days) 1.24M

Income Statement

In the last 12 months, Caribou Biosciences had revenue of 9.99M and earned -149.1M in profits. Earnings per share was -1.65.

Revenue 9.99M
Gross Profit 9.99M
Operating Income -166.62M
Net Income -149.1M
EBITDA -166.62M
EBIT -166.62M
Earnings Per Share (EPS) -1.65
Full Income Statement

Balance Sheet

The company has 16.29M in cash and 26.49M in debt, giving a net cash position of -10.19M.

Cash & Cash Equivalents 16.29M
Total Debt 26.49M
Net Cash -10.19M
Retained Earnings -448.39M
Total Assets 313.31M
Working Capital 188.73M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -138.2M and capital expenditures -4.88M, giving a free cash flow of -143.08M.

Operating Cash Flow -138.2M
Capital Expenditures -4.88M
Free Cash Flow -143.08M
FCF Per Share -1.58
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -1667.16% and -1491.95%.

Gross Margin 100%
Operating Margin -1667.16%
Pretax Margin -1492.04%
Profit Margin -1491.95%
EBITDA Margin -1667.16%
EBIT Margin -1667.16%
FCF Margin -1431.66%

Dividends & Yields

CRBU does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for CRBU is $11, which is 1292.4% higher than the current price. The consensus rating is "Buy".

Price Target $11
Price Target Difference 1292.4%
Analyst Consensus Buy
Analyst Count 5
Stock Forecasts

Scores

Altman Z-Score -2.23
Piotroski F-Score 2